Changes — raw log (20,312 events)
Every event the pipeline observed across all networks — payouts, statuses, geos, caps, metrics — one row per event, nothing filtered. Back to movements that matter. Subscribe: Atom feed.
| When | Network | Offer | Change |
|---|---|---|---|
| 3d ago | dr.cash | Jucyman Protency Max free | Approval rate 21.33% → 20% (-6.2%) |
| 3d ago | dr.cash | Masculanix low price | Approval rate 12.5% → 11.11% (-11.1%) |
| 3d ago | dr.cash | Uroprostan | Approval rate 33.33% → 28.57% (-14.3%) |
| 3d ago | dr.cash | Vianelle free | Approval rate 17.05% → 16.82% (-1.3%) |
| 3d ago | dr.cash | O caps | Approval rate 20% → 20.27% (+1.4%) |
| 3d ago | dr.cash | Elastica | Approval rate 82.35% → 88.89% (+7.9%) |
| 3d ago | dr.cash | Prostalis | Approval rate 21.67% → 28.57% (+31.8%) |
| 3d ago | dr.cash | Prostalis low price | Approval rate 41.18% → 47.06% (+14.3%) |
| 3d ago | dr.cash | Prostalis low price | Approval rate 73.33% → 77.97% (+6.3%) |
| 3d ago | dr.cash | Imperium low price | Approval rate 33.33% → 28.57% (-14.3%) |
| 3d ago | dr.cash | Clora Balance | Approval rate 60% → 57.89% (-3.5%) |
| 3d ago | dr.cash | Artex | Approval rate 50% → 25% (-50.0%) |
| 3d ago | dr.cash | MANTRIX (male urination) | Approval rate 45.45% → 41.67% (-8.3%) |
| 3d ago | dr.cash | Broten | Approval rate 64.29% → 70.37% (+9.5%) |
| 3d ago | dr.cash | Hairstim free | Approval rate 17.88% → 17.65% (-1.3%) |
| 3d ago | dr.cash | Flexosamine PRO | Approval rate 12.5% → 13.64% (+9.1%) |
| 3d ago | dr.cash | GlucoMax | Approval rate 35.29% → 31.25% (-11.4%) |
| 3d ago | dr.cash | HELMIRON | Approval rate 39.97% → 39.81% (-0.4%) |
| 3d ago | dr.cash | IdealFit low price | Approval rate 22.9% → 22.79% (-0.5%) |
| 3d ago | dr.cash | ArtiZynt Capsules low price | Approval rate 20% → 25% (+25.0%) |
| 3d ago | dr.cash | ArtiZynt Capsules low price | Approval rate 4.65% → 4.26% (-8.4%) |
| 3d ago | dr.cash | Glucoven free | Approval rate 23.34% → 23.72% (+1.6%) |
| 3d ago | dr.cash | CYSTOBACT | Approval rate 37.5% → 40% (+6.7%) |
| 3d ago | dr.cash | VigorPlus | Approval rate 18% → 17.39% (-3.4%) |
| 3d ago | dr.cash | OSTEFRIN | Approval rate 38.89% → 38.71% (-0.5%) |
| 3d ago | dr.cash | Diapril low price | Approval rate 75% → 66.67% (-11.1%) |
| 3d ago | dr.cash | Urinol PRO low price | Approval rate 9.6% → 9.44% (-1.7%) |
| 3d ago | dr.cash | Prostonel low price | Approval rate 33.33% → 12% (-64.0%) |
| 3d ago | dr.cash | Tricore | Approval rate 30% → 25% (-16.7%) |
| 3d ago | dr.cash | Tenurol | Approval rate 50% → 100% (+100.0%) |
| 3d ago | dr.cash | Tenurol | Approval rate 50% → 45.83% (-8.3%) |
| 3d ago | dr.cash | ArtiZynt Capsules low price | Approval rate 15.35% → 15.67% (+2.1%) |
| 3d ago | dr.cash | ArtiZynt caps low price | Approval rate 64.18% → 63.38% (-1.2%) |
| 3d ago | dr.cash | NixMen | Approval rate 11.89% → 12.41% (+4.4%) |
| 3d ago | dr.cash | ArtiZynt caps low price | Approval rate 33.33% → 45.45% (+36.4%) |
| 3d ago | dr.cash | ArtiZynt Caps low price | Approval rate 73.53% → 70.97% (-3.5%) |
| 3d ago | dr.cash | UroNature | Approval rate 43.82% → 42.11% (-3.9%) |
| 3d ago | dr.cash | EROPLEX (male urination) | Approval rate 1.52% → 1.43% (-5.9%) |
| 3d ago | dr.cash | Vitality Plus Ultra | Approval rate 42.86% → 42.31% (-1.3%) |
| 3d ago | dr.cash | Virilift | Approval rate 30% → 29.27% (-2.4%) |
| 3d ago | dr.cash | ARVION (sexual function) | Approval rate 22.22% → 20% (-10.0%) |
| 3d ago | dr.cash | ARVION (sexual function) | Approval rate 50.24% → 50.08% (-0.3%) |
| 3d ago | dr.cash | GlucoZen | Approval rate 50% → 66.67% (+33.3%) |
| 3d ago | dr.cash | Vigoraten low price | Approval rate 27.94% → 23.81% (-14.8%) |
| 3d ago | dr.cash | Variquit PRO | Approval rate 66.67% → 65.71% (-1.4%) |
| 3d ago | dr.cash | UP Lift Max | Approval rate 22.47% → 19.23% (-14.4%) |
| 3d ago | dr.cash | Mor Ginseng caps | Approval rate 8.39% → 7.92% (-5.6%) |
| 3d ago | dr.cash | DIZAXEN | Approval rate 66.67% → 75% (+12.5%) |
| 3d ago | dr.cash | DIZAXEN | Approval rate 57.14% → 53.85% (-5.8%) |
| 3d ago | dr.cash | VIZILAX | Approval rate 16.67% → 12.5% (-25.0%) |